The Experience of Patients with Cancer and Their Informal Caregivers Related to Adoptive Cell Therapy: A Qualitative Systematic Review.

IF 2.3 4区 医学 Q1 NURSING
Nina Canova, Kylie Teggart, Alexia Cavin-Trombert, Manuela Eicher, Francesca Bosisio, Sara Colomer-Lahiguera
{"title":"The Experience of Patients with Cancer and Their Informal Caregivers Related to Adoptive Cell Therapy: A Qualitative Systematic Review.","authors":"Nina Canova, Kylie Teggart, Alexia Cavin-Trombert, Manuela Eicher, Francesca Bosisio, Sara Colomer-Lahiguera","doi":"10.1016/j.soncn.2025.151912","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Adoptive cell therapy (ACT) is a growing personalized immuno-oncology approach, delivered both in standard of care (SOC) and clinical trial (CT) settings. Understanding patient and informal caregivers (ICs) experiences is crucial to optimizing care. This qualitative systematic review explores the ACT experience across three elements: actors (patients and ICs), settings (CT and SOC), and phases of the care continuum.</p><p><strong>Methods: </strong>A systematic search was conducted across Medline, Embase, CINAHL, APA PsycInfo, Cochrane, Web of Science, ProQuest Dissertations & Theses, and Google Scholar up to May 8, 2024. Studies were appraised using the JBI Critical Appraisal Checklist for Qualitative Research, with data extracted and synthesized using a meta-aggregation approach. MAXQDA was used to generate co-occurrence networks between key elements and inductively derived codes. A comparative sentiment analysis highlighted emotional differences between CT and SOC settings.</p><p><strong>Results: </strong>Nineteen qualitative studies were included, capturing experiences of patients (n = 19) and ICs (n = 7) receiving chimeric antigen receptor T cell (n = 17) and tumor-infiltrating lymphocyte (n = 2) therapy in CT (n = 13) and SOC (n = 9) settings. Findings revealed phase-specific challenges across physical, cognitive, psychological, emotional, social, financial, professional, communication, and informational domains. These challenges originate from ACT-related toxicities, care pathway complexity, and the novel nature of the therapy.</p><p><strong>Conclusions: </strong>This review identifies the key challenges faced by patients and ICs throughout the ACT care pathway, emphasizing the need for tailored interventions based on the phase and setting, as well as improved support systems.</p><p><strong>Implications for nursing practices: </strong>Recommended strategies include developing decision support tools, establishing caregiver support programs, and implementing navigation services to enhance patient and ICs experiences.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151912"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Oncology Nursing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.soncn.2025.151912","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Adoptive cell therapy (ACT) is a growing personalized immuno-oncology approach, delivered both in standard of care (SOC) and clinical trial (CT) settings. Understanding patient and informal caregivers (ICs) experiences is crucial to optimizing care. This qualitative systematic review explores the ACT experience across three elements: actors (patients and ICs), settings (CT and SOC), and phases of the care continuum.

Methods: A systematic search was conducted across Medline, Embase, CINAHL, APA PsycInfo, Cochrane, Web of Science, ProQuest Dissertations & Theses, and Google Scholar up to May 8, 2024. Studies were appraised using the JBI Critical Appraisal Checklist for Qualitative Research, with data extracted and synthesized using a meta-aggregation approach. MAXQDA was used to generate co-occurrence networks between key elements and inductively derived codes. A comparative sentiment analysis highlighted emotional differences between CT and SOC settings.

Results: Nineteen qualitative studies were included, capturing experiences of patients (n = 19) and ICs (n = 7) receiving chimeric antigen receptor T cell (n = 17) and tumor-infiltrating lymphocyte (n = 2) therapy in CT (n = 13) and SOC (n = 9) settings. Findings revealed phase-specific challenges across physical, cognitive, psychological, emotional, social, financial, professional, communication, and informational domains. These challenges originate from ACT-related toxicities, care pathway complexity, and the novel nature of the therapy.

Conclusions: This review identifies the key challenges faced by patients and ICs throughout the ACT care pathway, emphasizing the need for tailored interventions based on the phase and setting, as well as improved support systems.

Implications for nursing practices: Recommended strategies include developing decision support tools, establishing caregiver support programs, and implementing navigation services to enhance patient and ICs experiences.

癌症患者及其非正式照顾者与过继细胞治疗相关的经验:一项质性系统回顾。
目的:过继细胞疗法(ACT)是一种不断发展的个性化免疫肿瘤学方法,可在标准治疗(SOC)和临床试验(CT)环境中进行。了解患者和非正式护理人员(ic)的经验对于优化护理至关重要。这篇定性系统综述探讨了ACT在三个方面的经验:参与者(患者和ic)、环境(CT和SOC)和护理连续体的各个阶段。方法:系统检索截至2024年5月8日的Medline、Embase、CINAHL、APA PsycInfo、Cochrane、Web of Science、ProQuest dissertis&thesis和谷歌Scholar。使用JBI定性研究关键评估清单对研究进行评估,并使用元聚合方法提取和合成数据。MAXQDA用于生成关键元件与归纳衍生代码之间的共现网络。对比情绪分析强调了CT和SOC设置之间的情绪差异。结果:19包括定性研究,获取患者的经验(n = 19)和ICs (n = 7)接收嵌合抗原受体T细胞(n = 17)和肿瘤浸润淋巴细胞(n = 2)治疗CT (n = 13)和SOC (n = 9)设置。研究结果揭示了生理、认知、心理、情感、社会、财务、专业、沟通和信息领域的阶段性挑战。这些挑战源于act相关的毒性、护理途径的复杂性和治疗的新颖性。结论:本综述确定了患者和ic在整个ACT治疗途径中面临的主要挑战,强调需要根据阶段和环境进行量身定制的干预措施,以及改进的支持系统。对护理实践的影响:建议的策略包括开发决策支持工具,建立护理人员支持计划,以及实施导航服务以提高患者和ic的体验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seminars in Oncology Nursing
Seminars in Oncology Nursing Nursing-Oncology (nursing)
CiteScore
3.40
自引率
0.00%
发文量
68
审稿时长
45 days
期刊介绍: Seminars in Oncology Nursing is a unique international journal published six times a year. Each issue offers a multi-faceted overview of a single cancer topic from a selection of expert review articles and disseminates oncology nursing research relevant to patient care, nursing education, management, and policy development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信